Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.11851/11601
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Erdoğan, G. | - |
dc.contributor.author | Yücel, E. | - |
dc.contributor.author | Kiavash, P. | - |
dc.contributor.author | Salman, F.S. | - |
dc.date.accessioned | 2024-06-19T14:55:33Z | - |
dc.date.available | 2024-06-19T14:55:33Z | - |
dc.date.issued | 2024 | - |
dc.identifier.issn | 0038-0121 | - |
dc.identifier.uri | https://doi.org/10.1016/j.seps.2024.101895 | - |
dc.identifier.uri | https://hdl.handle.net/20.500.11851/11601 | - |
dc.description.abstract | This paper presents a novel model for the Vaccine Allocation Problem (VAP), which aims to allocate the available vaccines to population locations over multiple periods during a pandemic. We model the disease progression and the impact of vaccination on the spread of the disease and mortality to minimise total expected mortality and location inequity in terms of mortality ratios under total vaccine supply and hospital and vaccination centre capacity limitations at the locations. The spread of the disease is modelled through an extension of the well-established Susceptible–Infected–Recovered (SIR) epidemiological model that accounts for multiple vaccine doses. The VAP is modelled as a nonlinear mixed-integer programming model and solved to optimality using the Gurobi solver. A set of scenarios with parameters regarding the COVID-19 pandemic in the UK over 12 weeks are constructed using a hypercube experimental design on varying disease spread, vaccine availability, hospital capacity, and vaccination capacity factors. The results indicate the statistical significance of vaccine availability and the parameters regarding the spread of the disease. © 2024 Elsevier Ltd | en_US |
dc.description.sponsorship | Türkiye Bilimsel ve Teknolojik Araştırma Kurumu, TÜBİTAK: TR 220N017, 220N017; Türkiye Bilimsel ve Teknolojik Araştırma Kurumu, TÜBİTAK; Newton Fund, NF: 623795194; Newton Fund, NF | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Ltd | en_US |
dc.relation.ispartof | Socio-Economic Planning Sciences | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | COVID-19 pandemic | en_US |
dc.subject | Fairness | en_US |
dc.subject | Nonlinear mixed integer program | en_US |
dc.subject | Optimisation | en_US |
dc.subject | Vaccine allocation | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | disease spread | en_US |
dc.subject | epidemic | en_US |
dc.subject | epidemiology | en_US |
dc.subject | optimization | en_US |
dc.subject | vaccination | en_US |
dc.subject | vaccine | en_US |
dc.subject | United Kingdom | en_US |
dc.title | Fair and Effective Vaccine Allocation During a Pandemic | en_US |
dc.type | Article | en_US |
dc.department | TOBB ETÜ | en_US |
dc.identifier.volume | 93 | en_US |
dc.identifier.wos | WOS:001239761200001 | en_US |
dc.identifier.scopus | 2-s2.0-85192092622 | en_US |
dc.institutionauthor | Yücel, E. | - |
dc.identifier.doi | 10.1016/j.seps.2024.101895 | - |
dc.authorscopusid | 14519209700 | - |
dc.authorscopusid | 24773991000 | - |
dc.authorscopusid | 59014066100 | - |
dc.authorscopusid | 7003751168 | - |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
item.openairetype | Article | - |
item.languageiso639-1 | en | - |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | 02.4. Department of Industrial Engineering | - |
Appears in Collections: | Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
WEB OF SCIENCETM
Citations
1
checked on Dec 21, 2024
Page view(s)
96
checked on Dec 16, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.